跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MELOXADIN ORAL SUSPENSION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MELOXADIN ORAL SUSPENSION
Authorized
STANDARD
MELOXADIN ORAL SUSPENSION
NORBROOK LABORATORIES LTD.
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
d37e1ed8042d73f2
Company
NORBROOK LABORATORIES LTD.
Type
Standard
Approval Details
Approval Id
d37e1ed8042d73f2
Drug Approval Canada Name
MELOXADIN ORAL SUSPENSION
Product Name
MELOXADIN ORAL SUSPENSION
Status
Marketed
Status Date
2019-10-09
Original Market Date
2019-10-09
Din
MELOXADIN ORAL SUSPENSION
Drug Class
Veterinary
Dosage Form
Suspension
Route Of Administration
Oral
Schedule
PRESCRIPTION
Atc Original
Not Applicable
Aig Number
0131676001
Company Name
NORBROOK LABORATORIES LTD.
Company Address
Carnbane Industrial Estate Newry Northern Ireland United Kingdom BT35 6QQ
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
d37e1ed8042d73f2
Type
Standard
Back to Health Canada Approvals